Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Testosterone and Dutasteride PK Study (ORAL T-3)
NCT00161421Phase 2Completed
- Sponsor
- University of Washington
- Start
- Mar 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of testosterone in Hypogonadism and male contraception, sponsored by University of Washington. Primary endpoint: Elevations in serum testosterone at 2 months. Started Mar 2005; status: completed.
02
Drugs
testosterone
03
Conditions
Hypogonadismmale contraception
Beyond the preview
Go deeper on NCT00161421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161421.